Mahesh Gajendran

Texas Tech University

Papers

1

Total Citations

7

H-Index

1

About

Dr. Mahesh Gajendran is a leading clinician-scientist whose research focuses on the intersection of advanced surgical robotics and complex gastrointestinal disorders, particularly in patients with systemic autoimmune diseases. His most notable contribution is the pioneering evaluation of robotic Dor fundoplication for treating severe gastroesophageal reflux disease (GERD) in patients with scleroderma (systemic sclerosis). This work is critical, as nearly 80% of scleroderma patients suffer from debilitating GERD and dysphagia, with nocturnal reflux posing life-threatening risks of aspiration. By demonstrating the efficacy and safety of this minimally invasive approach, Dr. Gajendran has opened new therapeutic avenues for a population often deemed too high-risk for conventional surgery. His 2021 study, which has already garnered 7 citations, underscores the growing recognition of his work in reshaping surgical standards for connective tissue disease patients. Beyond this, his broader research portfolio addresses the pathophysiology of gastrointestinal dysmotility and the optimization of robotic surgical techniques. Dr. Gajendran’s contributions are not only advancing surgical practice but also improving quality of life for some of the most vulnerable patients with chronic, multisystem disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy and Safety of Robotic Dor Fundoplication on Severe Gastroesophageal Reflux Disease in Patients With Scleroderma
7 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Texas Tech University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago